BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20420633)

  • 1. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma.
    Panjala C; Senecal DL; Bridges MD; Kim GP; Nakhleh RE; Nguyen JH; Harnois DM
    Am J Transplant; 2010 May; 10(5):1263-7. PubMed ID: 20420633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longterm prognosis of combined hepatocellular carcinoma-cholangiocarcinoma following liver transplantation and resection.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG
    Liver Transpl; 2017 Mar; 23(3):330-341. PubMed ID: 28027599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Yoon YI; Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee JW; Hong SM; Yu ES; Lee SG
    J Gastrointest Surg; 2016 Feb; 20(2):411-20. PubMed ID: 26628072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.
    Tang D; Nagano H; Nakamura M; Wada H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M
    J Gastrointest Surg; 2006; 10(7):987-98. PubMed ID: 16843869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of incidental/misdiagnosed intrahepatic cholangiocarcinoma and combined hepatocellular cholangiocarcinoma on the outcomes of liver transplantation: an institutional case series and literature review.
    Gupta R; Togashi J; Akamatsu N; Sakamoto Y; Kokudo N
    Surg Today; 2017 Aug; 47(8):908-917. PubMed ID: 28124125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgery.
    Lee SD; Park SJ; Han SS; Kim SH; Kim YK; Lee SA; Ko YH; Hong EK
    Hepatobiliary Pancreat Dis Int; 2014 Dec; 13(6):594-601. PubMed ID: 25475861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 8. Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection.
    Song P; Midorikawa Y; Nakayama H; Higaki T; Moriguchi M; Aramaki O; Yamazaki S; Aoki M; Teramoto K; Takayama T
    Cancer Med; 2019 Oct; 8(13):5862-5871. PubMed ID: 31407490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases.
    Yano Y; Yamamoto J; Kosuge T; Sakamoto Y; Yamasaki S; Shimada K; Ojima H; Sakamoto M; Takayama T; Makuuchi M
    Jpn J Clin Oncol; 2003 Jun; 33(6):283-7. PubMed ID: 12913082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation in patients with incidental hepatocellular carcinoma/cholangiocarcinoma and intrahepatic cholangiocarcinoma: a single-center experience.
    Elshamy M; Presser N; Hammad AY; Firl DJ; Coppa C; Fung J; Aucejo FN
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):264-270. PubMed ID: 28603094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes of combined hepatocellular-cholangiocarcinoma after hepatectomy or liver transplantation: A systematic review and meta-analysis.
    Li DB; Si XY; Wang SJ; Zhou YM
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):12-18. PubMed ID: 30442549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery.
    Zhang H; Yu X; Xu J; Li J; Zhou Y
    Medicine (Baltimore); 2019 Sep; 98(38):e17102. PubMed ID: 31567946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database.
    Vilchez V; Shah MB; Daily MF; Pena L; Tzeng CW; Davenport D; Hosein PJ; Gedaly R; Maynard E
    HPB (Oxford); 2016 Jan; 18(1):29-34. PubMed ID: 26776848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiological features and outcomes of combined hepatocellular-cholangiocarcinoma in patients undergoing surgical resection.
    Chi CT; Chau GY; Lee RC; Chen YY; Lei HJ; Hou MC; Chao Y; Huang YH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):125-133. PubMed ID: 30876788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation versus liver resection and liver transplantation for small combined hepatocellular-cholangiocarcinoma stratified by tumor size.
    Peng S; Dong SC; Bai DS; Zhang C; Jin SJ; Jiang GQ
    Langenbecks Arch Surg; 2023 Mar; 408(1):119. PubMed ID: 36918430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors of Tumor Recurrence After Liver Transplantation for Combined Hepatocellular Carcinoma and Cholangiocarcinoma.
    Park WK; Joshi PK; Lee KW; Lee KB; Hong SK; Yoon KC; Lee JM; Cho JH; Yi NJ; Suh KS
    Transplant Proc; 2020; 52(1):271-275. PubMed ID: 31926744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed Hepatocellular Cholangiocarcinoma: A Review of Long-Term Outcomes Following Liver Transplantation.
    Machairas N; Stamopoulos P; Kostakis ID; Garoufalia Z; Paspala A; Tsaparas P; Sotiropoulos GC
    Transplant Proc; 2019 Mar; 51(2):437-439. PubMed ID: 30879560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-Center Analysis of Liver Transplantation for Combined Hepatocellular Carcinoma-Cholangiocarcinoma Liver Tumors.
    Dageforde LA; Vachharajani N; Tabrizian P; Agopian V; Halazun K; Maynard E; Croome K; Nagorney D; Hong JC; Lee D; Ferrone C; Baker E; Jarnagin W; Hemming A; Schnickel G; Kimura S; Busuttil R; Lindemann J; Florman S; Holzner ML; Srouji R; Najjar M; Yohanathan L; Cheng J; Amin H; Rickert CA; Yang JD; Kim J; Pasko J; Chapman WC; Majella Doyle MB
    J Am Coll Surg; 2021 Apr; 232(4):361-371. PubMed ID: 33316425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.